Pharmaceutical Revalidation of Shwasakuthara Rasa and its Preclinical Safety and Phase I-II Dose Determination (Safety &Efficacy) Study

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年2月21日

试验速览

暂无简介。

•Phase I- Healthy volunteers of either sex, age 20-60 years, belongs from same socio-economical condition, follow same dietary regimen and life style who willing to participate in the study will be enrolled after obtaining informed consent from each volunteer.
•Phase II- Diagnosed case of mild and moderate persistent bronchial asthma who are willing to participate in this study by giving his/her consent during the course of work, Both the sexes having age between 20 years to 60 years.

•Phase I-Healthy person who donâ??t want to participate, evidence of significant physical abnormalities, history of chronic medication within the past 6 weeks, history of hypersensitivity to any medication, regular smokers who smoke more than 10 cigarettes daily or have difficulty in abstaining from smoking during the study duration, history of drug dependence or chronic alcohol use, women with anticipated pregnancy/pregnant/lactating/ using oral contraceptives.
•Phase II- Dyspnea resulting from other diseases like left ventricular failure, upper respiratory tract obstruction, bronchiectasis, cases of tuberculosis, interstitial lung disease/occupational lung disease, tropical pulmonary eosinophilia & allergic bronchopulmonary aspergillosis etc. Patients having anemia, pneumonia, tuberculosis, lung cancer, lung abscess and other such complicated conditions, Patients having diabetes, hypertension, Chronic and Acute renal failure etc. conditions in which urination is markedly diminished or excessive will be excluded, HIV, Pregnant/ lactating mother, Patient taking conventional medication.

发起方